Alatyyat, S. M., Alasmari, H. M., Aleid, O. A., Abdel-Maksoud, M. S., & Elsherbiny, N. (2020). Umbilical cord stem cells: Background, processing and applications. Tissue and Cell, 65, 101351.

Almuqbil, R. M., Heyder, R. S., Bielski, E. R., Durymanov, M., Reineke, J. J., & da Rocha, S. R. P. (2020). Dendrimer conjugation enhances tumor penetration and efficacy of doxorubicin in extracellular matrix-expressing 3D lung cancer models. Molecular Pharmaceutics, 17(5), 1648–1662.

Bullard, J. D., Lei, J., Lim, J. J., Massee, M., Fallon, A. M., & Koob, T. J. (2019). Evaluation of dehydrated human umbilical cord biological properties for wound care and soft tissue healing. Journal of Biomedical Materials Research, Part B, Applied Biomaterials, 107(4), 1035–1046.

Cao, L., Zhao, S., Yang, Q., Shi, Z., Liu, J., Pan, T., Zhou, D., & Zhang, J. (2021). Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer. Frontiers in Oncology, 11, 614458.

Chatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S. (2010). Doxorubicin cardiomyopathy. Cardiology, 115(2), 155–162.

Chen, F., Zhong, X., Dai, Q., Li, K., Zhang, W., Wang, J., Zhao, Y., Shen, J., Xiao, Z., Xing, H., & Li, J. (2022). Human umbilical cord MSC delivered-soluble TRAIL inhibits the proliferation and promotes apoptosis of B-ALL cell in vitro and in vivo. Pharmaceuticals, 15(11), 1391.

Chez, M., Lepage, C., Parise, C., Dang-Chu, A., Hankins, A., & Carroll, M. (2018). Safety and observations from a placebo-controlled, crossover study to assess use of autologous umbilical cord blood stem cells to improve symptoms in children with autism. Stem Cells Translational Medicine, 7(4), 333–341.

Ding, D. C., Shyu, W. C., & Lin, S. Z. (2011). Mesenchymal stem cells. Cell Transplantation, 20(1), 5–14.

Elmore S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35(4), 495–516.

Galieva, L. R., Mukhamedshina, Y. O., Arkhipova, S. S., & Rizvanov, A. A. (2017). Human umbilical cord blood cell transplantation in neuroregenerative strategies. Frontiers in Pharmacology, 8, 628.

Guo, Y., Tang, Y., Lu, G., & Gu, J. (2023). p53 at the crossroads between doxorubicin-induced cardiotoxicity and resistance: A nutritional balancing act. Nutrients, 15(10), 2259.

He, J., Ao, C., Li, M., Deng, T., Zheng, S., Zhang, K., Tu, C., Ouyang, Y., Lang, R., Jiang, Y., Yang, Y., Li, C., & Wu, D. (2024). Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K/ AKT pathway. Stem Cell Research and Therapy, 15(1), 300.

Heydari, P., Zargar Kharazi, A., & Shariati, L. (2024). Enhanced wound regeneration by PGS/PLA fiber dressing containing platelet-rich plasma: An in vitro study. Scientific Reports, 14(1), 12019.

Hong, B., Lee, S., Shin, N., Ko, Y., Kim, D., Lee, J., & Lee, W. (2018). Bone regeneration with umbilical cord blood mesenchymal stem cells in femoral defects of ovariectomized rats. Osteoporosis and Sarcopenia, 4(3), 95–101.

Ketelut-Carneiro, N., & Fitzgerald, K. A. (2022). Apoptosis, pyroptosis, and necroptosis – oh my! the many ways a cell can die. Journal of Molecular Biology, 434(4), 167378.

Kim, S. Y., Kim, S. J., Kim, B. J., Rah, S. Y., Chung, S. M., Im, M. J., & Kim, U. H. (2006). Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. Experimental and Molecular Medicine, 38(5), 535–545.

Martorana, F., Motta, G., Pavone, G., Motta, L., Stella, S., Vitale, S. R., Manzella, L., & Vigneri, P. (2021). AKT inhibitors: New weapons in the fight against breast cancer? Frontiers in Pharmacology, 12, 662232.

Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004). Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological Reviews, 56(2), 185–229.

Morana, O., Wood, W., & Gregory, C. D. (2022). The apoptosis paradox in cancer. International Journal of Molecular Sciences, 23(3), 1328.

Peng, Y., Wang, Y., Zhou, C., Mei, W., & Zeng, C. (2022). PI3K/Akt/mTOR pathway and its role in cancer therapeutics: Are we making headway? Frontiers in Oncology, 12, 819128.

Prado, N. O., Lalli, L. A., Blanes, L., Zanette, D. L., & Aoki, M. N. (2023). Lyophilization of molecular biology reactions: A review. Mini Reviews in Medicinal Chemistry, 23(4), 480–496.

Sun, X., Hao, H., Han, Q., Song, X., Liu, J., Dong, L., Han, W., & Mu, Y. (2017). Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Research and Therapy, 8(1), 241.

Sun, Y., Liu, W. Z., Liu, T., Feng, X., Yang, N., & Zhou, H. F. (2015). Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. Journal of Receptor and Signal Transduction Research, 35(6), 600–604.

Tacar, O., & Dass, C. R. (2013). Doxorubicin-induced death in tumour cells and cardiomyocytes: Is autophagy the key to improving future clinical outcomes? The Journal of Pharmacy and Pharmacology, 65(11), 1577–1589.

Vanhaesebroeck, B., Perry, M. W. D., Brown, J. R., André, F., & Okkenhaug, K. (2021). PI3K inhibitors are finally coming of age. Nature Reviews. Drug Discovery, 20(10), 741–769.

Wen, X., Jiao, L., & Tan, H. (2022). MAPK/ERK pathway as a central regulator in vertebrate organ regeneration. International Journal of Molecular Sciences, 23(3), 1464.

Wiegand, C., & Hipler, U. C. (2008). Methods for the measurement of cell and tissue compatibility including tissue regeneration processes. GMS Krankenhaushygiene Interdisziplinar, 3(1), Doc12.

Yu, L., Wei, J., & Liu, P. (2022). Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Seminars in Cancer Biology, 85, 69–94.